Hui Yvonne
Known title: Principal Accounting OfficerCIK: 0002027089
Associated companies
Transaction History
| PHR | ▲ Buy | Grant | 43,000 | $0 | 9/1/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 1,247 | $14K | 7/16/2026 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 937 | $10K | 7/15/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 1,371 | $15K | 7/6/2026 | View on chart |
| PHR | ▲ Buy | Grant | 1,371 | $12K | 6/30/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 431 | $4K | 5/18/2026 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 325 | $3K | 5/18/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 1,327 | $12K | 4/17/2026 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 996 | $9K | 4/16/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 10,063 | $91K | 4/16/2026 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 314 | $3K | 4/15/2026 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 5,438 | $50K | 4/9/2026 | View on chart |
| PHR | ▲ Buy | Grant | 13,636 | — | 4/6/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 379 | $6K | 1/15/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 365 | $6K | 1/14/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 372 | $6K | 1/8/2026 | View on chart |
| PHR | ▲ Buy | Grant | 372 | $5K | 12/31/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 426 | $7K | 12/17/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 302 | $7K | 10/15/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 940 | $22K | 9/16/2025 | View on chart |
| PHR | ▲ Buy | Grant | 2,388 | — | 9/11/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 626 | $16K | 7/18/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 465 | $13K | 7/17/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 422 | $11K | 7/16/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 307 | $8K | 7/15/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 571 | $16K | 7/7/2025 | View on chart |
| PHR | ▲ Buy | Grant | 571 | $12K | 6/30/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 582 | $16K | 6/10/2025 | View on chart |
| PHR | ▲ Buy | Grant | 9,000 | $0 | 5/15/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 1,330 | $32K | 4/22/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 993 | $23K | 4/21/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 418 | $10K | 4/16/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 314 | $8K | 4/15/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 2,802 | $65K | 4/9/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 1,148 | $27K | 4/8/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 730 | $18K | 4/8/2025 | View on chart |
| PHR | ▲ Buy | Grant | 4,680 | — | 4/4/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 127 | $4K | 1/24/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 381 | $10K | 1/15/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 362 | $10K | 1/14/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 388 | $11K | 1/10/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 288 | $8K | 1/8/2025 | View on chart |
| PHR | ▲ Buy | Grant | 388 | $7K | 12/31/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 423 | $9K | 10/16/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 2,485 | $52K | 10/15/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 306 | $6K | 10/15/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 744 | $17K | 9/10/2024 | View on chart |
| PHR | ▲ Buy | Grant | 2,049 | — | 9/6/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 283 | $7K | 7/16/2024 | View on chart |
| PHR | ▲ Buy | Grant | 13,000 | $297K | 7/15/2024 | View on chart |
| PHR | ▲ Buy | Grant | 740 | $13K | 6/28/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Barclays Raises Phreesia Price Target to $11
Barclays has raised its price target for Phreesia to $11 while maintaining an Equal-Weight rating. This update places the firm's outlook within the broader analyst consensus, which currently averages $14.13. The stock remains well below its 52-week high of $24.07, reflecting a significant drop from previous levels.
Barclays Raises Phreesia Price Target to $11. Barclays has raised its price target for Phreesia to $11 while maintaining an Equal-Weight rating. This update places the firm's outlook within the broader analyst consensus, which currently averages $14.13. The stock remains well below its 52-week high of $24.07, reflecting a significant drop from previous levels.